Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Avet-Loiseau, H. (Hervé)
189  Ergebnisse:
Personensuche X
?
1

TCR-independent CD137 (4-1BB) signaling promotes CD8+-exhau..:

Pichler, Andrea C. ; Carrié, Nadège ; Cuisinier, Marine...
Immunity.  56 (2023)  7 - p. 1631-1648.e10 , 2023
Link: https://doi.org/10.1016/..
 
?
2

FlowCT for the analysis of large immunophenotypic data sets..:

Botta, C. (Cirino) ; Maia, C. (Catarina) ; Garcés-Latre, J.J. (Juan José)...
info:eu-repo/grantAgreement/EC/H2020/680200/EU.  , 2022
Link: https://hdl.handle.net/1..
 
?
3

OAB-008: Identification of high-risk Multiple Myeloma with ..:

Bruinink, Davine Hofste op ; Kuiper, Rowan ; Duin, Mark van...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S6 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Timing the initiation of multiple myeloma:

Rustad, Even H. ; Yellapantula, Venkata ; Leongamornlert, Daniel...
Nature Communications.  11 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
5

Daratumumab, lenalidomide, and dexamethasone in relapsed/re..:

Kaufman, Jonathan L. ; Dimopoulos, Meletios A. ; White, Darrell...
Blood Cancer Journal.  10 (2020)  11 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
6

Daratumumab, lenalidomide, and dexamethasone in relapsed/re..:

Kaufman, J.L. (Jonathan L.) ; Dimopoulos, M.A. (Meletios A.) ; White, D.J. (Darrell J.)...
https://hdl.handle.net/10171/65790.  , 2020
Link: https://hdl.handle.net/1..
 
?
7

A high-risk, Double-Hit, group of newly diagnosed myeloma i..:

Walker, B.A. (Brian A.) ; Mavrommatis, K. (Konstantinos) ; Wardell, C.P. (Christopher P.)...
https://hdl.handle.net/10171/62017.  , 2019
Link: https://hdl.handle.net/1..
 
?
8

Prevention and management of adverse events of novel agents..:

Ludwig, Heinz ; Delforge, Michel ; Facon, Thierry...
Leukemia.  32 (2018)  7 - p. 1542-1560 , 2018
Link: https://doi.org/10.1038/..
 
?
9

BMT CTN myeloma intergroup workshop on minimal residual dis..:

Holstein, S.A. (Sarah A.) ; Avet-Loiseau, H. (Herve) ; Hahn, T. (Theresa)...
info:eu-repo/grantAgreement/NIH/NATIONAL_HEART,_LUNG,_AND_BLOOD_INSTITUTE/2U10HL069294-11/US.  , 2018
Link: https://hdl.handle.net/1..
 
?
10

Prevention and management of adverse events of novel agents..:

Ludwig, H. (Heinz) ; Delforge, M. (M.) ; Facon, T. (Thierry)...
https://hdl.handle.net/10171/64747.  , 2018
Link: https://hdl.handle.net/1..
 
?
11

Prevention and management of adverse events of novel agents..:

Ludwig, H. (Heinz) ; Delforge, M. (Michel) ; Facon, T. (Thierry)...
http://repub.eur.nl/pub/114449.  , 2018
Link: http://repub.eur.nl/pub/..
 
?
12

A genome-wide association study identifies a novel locus fo..:

Magrangeas, F. (Florence) ; Kuiper, R. (Rowan) ; Avet-Loiseau, H. (Hervé)...
http://repub.eur.nl/pub/93421.  , 2016
Link: http://repub.eur.nl/pub/..
 
?
13

Treatment of multiple myeloma with high-risk cytogenetics: ..:

Sonneveld, P. (Pieter) ; Avet-Loiseau, H. (Hervé) ; Lonial, S. (Sagar)...
http://repub.eur.nl/pub/96804.  , 2016
Link: http://repub.eur.nl/pub/..
 
?
14

Prediction of high- and low-risk multiple myeloma based on ..:

Kuiper, R. (Rowan) ; Duin, M. (Mark) van ; Vliet, M.H. (Martin) van...
http://repub.eur.nl/pub/88969.  , 2015
Link: http://repub.eur.nl/pub/..
 
?
15

TCR-independent CD137 (4–1BB) signaling promotes CD8(+)-exh..:

Pichler, Andrea C ; Carrié, Nadège ; Cuisinier, Marine...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649891/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
1-15